Serge Beaulieu, MD, PhD, FRCPC, Director of the Mood, Anxiety and Impulsivity Disorders Program at the Douglas Institute, will chair the 43rd annual conference of the Association des médecins psychiatres du Québec (AMPQ). Bringing together nearly 400 specialists, the conference will be held from June 10 to 13 at the Fairmont Le Manoir Richelieu in Charlevoix. The theme of the conference will be "Des neurosciences à l'inconscient" (From neuroscience to the unconscious). 

Serge Beaulieu, MD, believes that this year's theme will help researchers better "understand how the various disciplines in our field, from neuroscience to psychoanalysis, have helped make great advances in psychiatry and improve our understanding of how mental illness develops."

The Institute will also be represented by Vasavan Nair, MD, FRCPC, researcher and Medical Chief of the Program for Dementia with Psychiatric Co-morbidity (PDPC), and researcher Maurice Dongier, MD, FRCPC. Accompanied by Dominique Sarfone, they will open the conference with a discussion on the role of neuroscience and how it has advanced knowledge in tandem with psychoanalysis.

The symposium Des neurosciences aux réalités cliniques pour prévenir le suicide au Québec, held wednesday, is conducted by lecturers from the McGill Group for Suicide Studies. Four researchers from the Douglas Institute, Naguib Mechawar, PhD, Johanne Renaud, MD, MSc, Monique Seguin PhD, Gustavo Turecki, MD, PhD, are members of the panel.

Suzanne Dongier, MD, Jens Pruessner, PhD, and Suzanne Renaud, MD, are also invited as lecturers.